26 results
424B5
IMPLQ
Impel Pharmaceuticals Inc
5 Oct 23
Prospectus supplement for primary offering
5:19pm
governance practices.
As a public company, and particularly after we are no longer an emerging growth company, we will continue to incur significant legal … and financial controls and corporate governance practices. We will need to hire additional accounting, finance and other personnel and make further
PRE 14A
66o0b49a4nyp4o9tlqn
14 Apr 23
Preliminary proxy
4:11pm
8-K
c39l8 oj4lun0a
12 Apr 23
Departure of Directors or Certain Officers
4:06pm
10-K/A
EX-3.2
77nxb4hf6cvkd hdtda4
31 Mar 23
Annual report (amended)
4:21pm
S-3
EX-1.2
lhn7n8lf 7700x1x311u
16 May 22
Shelf registration
4:49pm
DEF 14A
1nacpi p3
26 Apr 22
Definitive proxy
4:16pm
10-K
pmfhis
29 Mar 22
Annual report
5:09pm
424B4
fzui4yf8a
10 Sep 21
Prospectus supplement with pricing info
4:01pm
DRS
uwc 5ov452etw3
25 Aug 21
Draft registration statement
12:00am
10-Q
EX-3.2
ckhnagr
7 Jun 21
Quarterly report
7:17am